Product Program year 2019 Source: CMS Open Payments

Fitusiran

Drug

Open in the dashboard

General payments

$73,122

86 payments

Research payments

$453,869

102 payments

Through program year 2019, $73,122 in general payments and $453,869 in research payments were reported against Fitusiran.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $73,122 86
2019 Research $453,869 102

Breakdown

Who paid General payments · program year 2019
  1. Bioverativ Therapeutics Inc. $73,066 84 payments
  2. Sanofi-Aventis U.S. LLC $56 2 payments
Top recipients General payments · program year 2019
  1. Michael Wang Pediatric Hematology-Oncology · Aurora, CO $17,495 24% · 16 payments
  2. Shawn Jobe Pediatric Hematology-Oncology · Lansing, MI $13,450 18% · 12 payments
  3. Lisa Boggio Hematology & Oncology · Chicago, IL $11,239 15% · 18 payments
  4. Nidra Rodriguez Pediatric Hematology-Oncology · Houston, TX $8,796 12% · 10 payments
  5. Meera Chitlur Pediatrics · Detroit, MI $8,059 11% · 8 payments

The top 5 of 9 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Pediatric Hematology-Oncology Pediatrics $53,796 74% · 6 practitioners
  2. Hematology & Oncology Internal Medicine $11,267 15% · 2 practitioners
  3. Pediatrics $8,059 11% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2019
  1. Colorado $17,495 24% · 1 recipient
  2. Michigan $15,472 21% · 2 recipients
  3. Wisconsin $13,450 18% · 1 recipient
  4. Illinois $11,239 15% · 1 recipient
  5. Texas $8,796 12% · 1 recipient

The top 5 of 7 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

86 general · 102 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record